Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-05

Clinical Trial Update: To Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity. [Phase 3]

View source ↗

Summary

A Phase 3 study compared an 8% arginine toothpaste with Colgate Cavity Protection to evaluate reduction of dentinal hypersensitivity; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colgate Cavity Protection toothpaste (toothpaste)
  • Toothpaste containing 8% arginine (arginine-containing toothpaste)

Snippet

Sponsor: Colgate Palmolive | Conditions: Sensitivity, Tooth | Phase 3 | Status: COMPLETED